What is visceral fat and why is it more dangerous than regular fat?

Visceral adipose tissue is metabolically active in a way subcutaneous fat is not: it secretes pro-inflammatory cytokines (IL-6, TNF-α) directly into the portal circulation, drives hepatic insulin resistance, converts testosterone to estradiol via aromatase enzyme, and generates free fatty acids that directly impair cardiac function, creating a self-amplifying cycle of hormonal disruption, metabolic dysfunction, and further abdominal fat accumulation that makes visceral fat reduction qualitatively different from, and more cardiovascularly urgent than, general weight loss (Despres & Lemieux, Nature, 2006).

Visceral fat wraps around the abdominal organs (liver, pancreas, intestines). Unlike subcutaneous fat (which is deposited under the skin), visceral fat is anatomically positioned to deliver its inflammatory outputs directly to the liver via the portal vein. This portal drainage means that the inflammatory cytokines, free fatty acids, and aromatase products from visceral fat hit the liver at high concentration before being diluted in systemic circulation. Hepatic insulin resistance, one of the most significant metabolic drivers of type 2 diabetes, begins with this visceral fat-portal liver axis.

Honesty Scale: Solid (1). The pathophysiology of visceral fat is among the most thoroughly documented in metabolic medicine.

What to do: Stop thinking about your "belly fat" as a cosmetic problem. Measure your waist circumference at the navel. Above 40 inches (102 cm) in men is the threshold for metabolically significant visceral adiposity in standard clinical guidelines, though emerging evidence suggests the risk increases substantially above 37 inches (94 cm) in most male ethnicities.

For the full picture, read The Visceral Fat Deep Dive